Clinical Trial

Comparison Between Intrathecal Magnesium Sulphate & Dexmedetomidine in DHS

Name: Comparison Between Intrathecal Magnesium Sulphate & Dexmedetomidine in DHS — clinical trial record (NCT07326397)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To compare the efficacy and safety of intrathecal dexmedetomidine and magnesium sulphate as adjuvants to 0.5% hyperbaric bupivacaine in patients undergoing elective DHS fixation, focusing on onset and duration of sensory and motor block, hemodynamic stability, and quality of postoperative analgesia.

Trial Details

NCT Number	NCT07326397
Lead Sponsor	Assiut University
Conditions	Effects of Dexmedetomidine & Magnesium Sulphate on Patients Undergoing DHS
Enrollment	92 participants
Start Date	2026-02-01
Primary Completion	2027-11-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-08